Cell Signaling Technology
6 Results
詳細検索
種類別絞り込み
製品情報 (0)
技術資料 (0)
関連ページ (6)
-
-
Cell Signaling Multiplex Assays Using Luminex® Technology | Life Science Research | Merck
Cell signaling multiplex assays enable accurate relative quantitation of total and phosphorylated forms of signaling proteins, revealing connections within your networks of interest. -
Post-Translational Modifications | Life Science Research | Merck
Post-translational modifications (PTM) affect signaling proteins which makes the study of cell signaling pathways challenging. Our technologies for signaling research, combined with validated antibodies for proteins and PTMs, enable you to choose the perfect assay. -
Cancer Multiplex Assays Using Luminex® Technology | Life Science Research | Merck
Our cancer multiplex assays include soluble cancer analyte multiplex kits, inflammation and immune response cytokine/chemokine kits, and MAPmates cell signaling assays. -
Press Release: Merck Announces Agreement to Sell Amnis® Flow Cytometry and Guava® Technologies Businesses to Luminex Corporation
Merck today announced the signing of a definitive agreement to sell its Flow Cytometry unit to Luminex Corporation for €62.5 million. -
Validated antibodies for cutting-edge research | Merck
Decades ago, researchers at our Southern California laboratories realized the importance of developing precision reagents, called antibodies, to enable life scientists to distinguish these subtle chemical differences in signaling molecules. The Salk Institute for Biological Studies developed a new way to track some of the most elusive proteins in the body in particular, the unstable phosphohistidine. We have licensed the antibodies to help labs around the world use this technology.